Clinical significance of the Monoclonal Gammopathy of Undetermined Significance (MGUS) -like phenotype in patients with AL amyloidosis treated with Bortezomib-Containing Regimens (BCR) at the Amyloidosis Program of Calgary (APC) | Publicación